Endovascular Robotic System Reaches New Heights in Cutting-Edge Technology
Recently, the Beijing Innovative Medical Device Matchmaking and Medical Robot Scene Exhibition-a landmark event highlighting the nation's momentum in medical innovation-opened in the capital. The conference was hosted by the Beijing Municipal Science & Technology Commission (Administration of Zhongguancun Science Park) and the Beijing Municipal Hospital Management Center, and organized by the Tongzhou District Science & Technology Commission together with the Beijing Medical and Health Science & Technology Development Center.
As a national benchmark for independent innovation in medical technology, WeMed Medical's interventional robot carries a significant mission. It is the world's first Endovascular Robotic System to achieve integrated coordination of "Eye-Hand-Brain," and the first domestically developed system approved through the NMPA's Class III Innovative Medical Device Channel. Furthermore, it has been designated for national key research and development initiatives and is spearheading the formulation of industry standards.
At the exhibition, a representative from WeMed Medical delivered a speech titled "ROBOT DSA: Reshaping Interventional Procedures," presenting a professional perspective on how Endovascular Robotic System are redefining the boundaries of diagnosis and treatment. From precision control to intelligent assistance, and from the standardized execution of complex surgeries to the enhanced operational experience for physicians, every detail reflected WeMed Medical's expertise and forward-looking approach in medical robotics. The event was not merely a product showcase, but also a vivid testament to China's strength in independent innovation in medical technology.
WeMed Medical's debut on this state-sponsored, high-profile platform underscores national recognition of its leadership in interventional robotics. From laboratory research to clinical adoption, and from technological breakthroughs to real-world applications, the company is positioning its interventional robot as a driving force in advancing the globalization of China's high-end medical devices.
